Kirsten Raun - Publications

Affiliations: 
 

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Leuthardt AS, Boyle CN, Raun K, Lutz TA, John LM, Le Foll C. Body weight lowering effect of glucose-dependent insulinotropic polypeptide and glucagon-like peptide receptor agonists is more efficient in RAMP1/3 KO than in WT mice. European Journal of Pharmacology. 175912. PMID 37454968 DOI: 10.1016/j.ejphar.2023.175912  0.739
2022 Christoffersen BØ, Sanchez-Delgado G, John LM, Ryan DH, Raun K, Ravussin E. Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss. Obesity (Silver Spring, Md.). 30: 841-857. PMID 35333444 DOI: 10.1002/oby.23374  0.726
2022 Simonsen L, Lau J, Kruse T, Guo T, McGuire J, Jeppesen JF, Niss K, Sauerberg P, Raun K, Dornonville de la Cour C. Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls. Plos One. 17: e0264974. PMID 35245328 DOI: 10.1371/journal.pone.0264974  0.339
2021 Arrigoni S, Le Foll C, Cabak A, Lundh S, Raun K, John LM, Lutz TA. A selective role for receptor activity-modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice. The European Journal of Neuroscience. PMID 34189795 DOI: 10.1111/ejn.15376  0.745
2021 John LM, Kruse T, Raun K. Preclinical Weight Loss Efficacy of AM833 in Combination With Semaglutide in Rodent Models of Obesity Journal of the Endocrine Society. 5: A54-A54. DOI: 10.1210/jendso/bvab048.108  0.741
2021 Dahl K, John LM, Skyggebjerg RB, Vegge A, Andersen NK, Raun K. AM833, a Long Acting Amylin Analogue Induces Hypocalcemia in Young Rats via a Calcitonin Receptor Mediated Mechanism Journal of the Endocrine Society. 5: A43-A43. DOI: 10.1210/JENDSO/BVAB048.084  0.716
2020 Keinicke H, Sun G, Mentzel CMJ, Fredholm M, John LM, Andersen B, Raun K, Kjærgaard M. FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation. Endocrine Connections. PMID 32688339 DOI: 10.1530/Ec-20-0152  0.721
2020 Kalafateli AL, Vestlund J, Raun K, Egecioglu E, Jerlhag E. Effects of a selective long-acting amylin receptor agonist on alcohol consumption, food intake and body weight in male and female rats. Addiction Biology. 26: e12910. PMID 32383257 DOI: 10.1111/Adb.12910  0.342
2020 Gabery S, Salinas CG, Paulsen SJ, Ahnfelt-Rønne J, Alanentalo T, Baquero AF, Buckley ST, Farkas E, Fekete C, Frederiksen KS, Helms HCC, Jeppesen JF, John LM, Pyke C, Nøhr J, ... ... Raun K, et al. Semaglutide lowers body weight in rodents via distributed neural pathways. Jci Insight. 5. PMID 32213703 DOI: 10.1172/Jci.Insight.133429  0.736
2020 Zakariassen HL, John LM, Lykkesfeldt J, Raun K, Glendorf T, Schaffer L, Lundh S, Secher A, Lutz TA, Le Foll C. Salmon calcitonin distributes into the arcuate nucleus in mice to a subset of NPY neurons. Neuropharmacology. 107987. PMID 32035146 DOI: 10.1016/J.Neuropharm.2020.107987  0.712
2019 Zouhar P, Rakipovski G, Bokhari MH, Busby O, Paulsson JF, Conde-Frieboes KW, Fels JJ, Raun K, Andersen B, Cannon B, Nedergaard J. UCP1-independent glucose lowering effect of leptin in type 1 diabetes: only in conditions of hypoleptinemia. American Journal of Physiology. Endocrinology and Metabolism. PMID 31743040 DOI: 10.1152/Ajpendo.00253.2019  0.365
2019 Kjaergaard M, Salinas CBG, Rehfeld JF, Secher A, Raun K, Wulff BS. PYY(3-36) and exendin-4 reduce food intake and activate neuronal circuits in a synergistic manner in mice. Neuropeptides. 73: 89-95. PMID 30471778 DOI: 10.1016/J.Npep.2018.11.004  0.4
2019 Norlin JE, Galsgaard E, Bugge A, Hansen T, Lau J, Raun K, Latta MR, Holst D. FRI-305-Long acting GLP-1/Glucagon co-agonist ameliorates steatosis, inflammation and fibrogenesis in a rodent model of NASH Journal of Hepatology. 70. DOI: 10.1016/S0618-8278(19)31048-5  0.306
2018 Christoffersen B, Straarup EM, Lykkegaard K, Fels JJ, Sass-Ørum K, Zhang X, Raun K, Andersen B. FGF21 decreases food intake and body weight in obese Göttingen minipigs. Diabetes, Obesity & Metabolism. PMID 30328263 DOI: 10.1111/Dom.13560  0.447
2018 Hansen AMK, Vienberg SG, Lykkegaard K, Zhao X, Tingqing G, Han D, Zhang X, Thøgersen H, Sass-Ørum K, Tagmose TM, Raun K, Andersen B. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in mice. The Biochemical Journal. PMID 30127091 DOI: 10.1042/Bcj20180555  0.36
2018 Kjaergaard M, Nilsson C, Nielsen MO, Grove K, Raun K. Hypothalamic oxidative stress and inflammation, and peripheral glucose homeostasis in Sprague-Dawley rat offspring exposed to maternal and postnatal chocolate and soft drink. Nutrition & Diabetes. 8: 44. PMID 30026488 DOI: 10.1038/S41387-018-0051-Z  0.323
2018 Andersen B, Straarup EM, Heppner KM, Takahashi DL, Raffaele V, Dissen GA, Lewandowski K, Bödvarsdottir TB, Raun K, Grove KL, Kievit P. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys. International Journal of Obesity (2005). PMID 29892039 DOI: 10.1038/S41366-018-0080-7  0.434
2018 Johnsen L, Lyckegaard NB, Khanal P, Quistorff B, Raun K, Nielsen MO. Fetal over- and undernutrition differentially program thyroid axis adaptability in adult sheep. Endocrine Connections. 7: 777-790. PMID 29794141 DOI: 10.1530/Ec-18-0014  0.31
2017 Kjaergaard M, Nilsson C, Secher A, Kildegaard J, Skovgaard T, Nielsen MO, Grove K, Raun K. Differential hypothalamic leptin sensitivity in obese rat offspring exposed to maternal and postnatal intake of chocolate and soft drink. Nutrition & Diabetes. 7: e242. PMID 28092346 DOI: 10.1038/Nutd.2016.53  0.362
2016 Møller CL, Kjøbsted R, Enriori PJ, Jensen TE, Garcia-Rudaz C, Litwak SA, Raun K, Wojtaszewski J, Wulff BS, Cowley MA. α-MSH Stimulates Glucose Uptake in Mouse Muscle and Phosphorylates Rab-GTPase-Activating Protein TBC1D1 Independently of AMPK Plos One. 11. PMID 27467141 DOI: 10.1371/Journal.Pone.0157027  0.332
2016 Nilsson C, Hansen TK, Rosenquist C, Hartmann B, Kodra JT, Lau JF, Clausen TR, Raun K, Sams A. Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1. European Journal of Pharmacology. PMID 26808305 DOI: 10.1016/J.Ejphar.2016.01.003  0.405
2015 Petersen KE, Rakipovski G, Raun K, Lykkesfeldt J. Does glucagon-like peptide-1 ameliorate oxidative stress in diabetes? Evidence based on experimental and clinical studies. Current Diabetes Reviews. PMID 26381142 DOI: 10.2174/1573399812666150918150608  0.326
2015 Andersen B, Omar BA, Rakipovski G, Raun K, Ahrén B. Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes European Journal of Pharmacology. 764: 189-194. PMID 26144370 DOI: 10.1016/J.Ejphar.2015.07.003  0.378
2015 Ratner C, Madsen AN, Kristensen LV, Skov LJ, Pedersen KS, Mortensen OH, Knudsen GM, Raun K, Holst B. Impaired oxidative capacity due to decreased CPT1b levels as a contributing factor to fat accumulation in obesity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 308: R973-82. PMID 25855307 DOI: 10.1152/Ajpregu.00219.2014  0.337
2014 Secher A, Jelsing J, Baquero AF, Hecksher-Sørensen J, Cowley MA, Dalbøge LS, Hansen G, Grove KL, Pyke C, Raun K, Schäfer L, Tang-Christensen M, Verma S, Witgen BM, Vrang N, et al. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss Journal of Clinical Investigation. 124: 4473-4488. PMID 25202980 DOI: 10.1172/Jci75276  0.449
2014 Fosgerau K, Raun K, Nilsson C, Dahl K, Wulff BS. Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity Journal of Endocrinology. 220: 97-107. PMID 24204009 DOI: 10.1530/Joe-13-0284  0.449
2014 Omar BA, Andersen B, Hald J, Raun K, Nishimura E, Ahrén B. Fibroblast Growth Factor 21 (FGF21) and Glucagon Like-Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor Deficient Mice Diabetes. 63: 101-110. PMID 24062250 DOI: 10.2337/Db13-0710  0.348
2014 Kjaergaard M, Nilsson C, Rosendal A, Nielsen MO, Raun K. Maternal chocolate and sucrose soft drink intake induces hepatic steatosis in rat offspring associated with altered lipid gene expression profile. Acta Physiologica. 210: 142-153. PMID 23782871 DOI: 10.1111/Apha.12138  0.402
2013 Christoffersen B, Golozoubova V, Pacini G, Svendsen O, Raun K. The young Göttingen minipig as a model of childhood and adolescent obesity: Influence of diet and gender Obesity. 21: 149-158. PMID 23505180 DOI: 10.1002/Oby.20249  0.371
2012 Blædel M, Raun K, Boonen HCM, Sheykhzade M, Sams A. Early onset inflammation in pre-insulin-resistant diet-induced obese rats does not affect the vasoreactivity of isolated small mesenteric arteries. Pharmacology. 90: 125-132. PMID 22832366 DOI: 10.1159/000340054  0.324
2012 Conde-Frieboes K, Thøgersen H, Lau JF, Sensfuss U, Hansen TK, Christensen L, Spetzler J, Olsen HB, Nilsson C, Raun K, Dahl K, Hansen BS, Wulff BS. Identification and in vivo and in vitro characterization of long acting and melanocortin 4 receptor (MC4-R) selective α-melanocyte-stimulating hormone (α-MSH) analogues. Journal of Medicinal Chemistry. 55: 1969-77. PMID 22335602 DOI: 10.1021/Jm201489A  0.321
2012 Jelsing J, Vrang N, Hansen G, Raun K, Tang-Christensen M, Knudsen LB. Liraglutide: short-lived effect on gastric emptying -- long lasting effects on body weight. Diabetes, Obesity and Metabolism. 14: 531-538. PMID 22226053 DOI: 10.1111/J.1463-1326.2012.01557.X  0.458
2011 Zhang ZY, Zeng JJ, Kjaergaard M, Guan N, Raun K, Nilsson C, Wang MW. Effects of a maternal diet supplemented with chocolate and fructose beverage during gestation and lactation on rat dams and their offspring. Clinical and Experimental Pharmacology & Physiology. 38: 613-22. PMID 21722163 DOI: 10.1111/J.1440-1681.2011.05568.X  0.358
2011 Conde-Frieboes K, Ankersen M, Breinholt J, Hansen BS, Raun K, Thøgersen H, Wulff BS. Serendipitous discovery of a new class of agonists for the melanocortin 1 and 4 receptors and a new class of cyclophanes. Bioorganic & Medicinal Chemistry Letters. 21: 1459-1463. PMID 21277204 DOI: 10.1016/J.Bmcl.2011.01.011  0.362
2010 Cummings BP, Stanhope KL, Graham JL, Baskin DG, Griffen SC, Nilsson C, Sams A, Knudsen LB, Raun K, Havel PJ. Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats. Diabetes. 59: 2653-61. PMID 20622169 DOI: 10.2337/Db09-1564  0.418
2010 Christoffersen BO, Gade LP, Golozoubova V, Svendsen O, Raun K. Influence of castration-induced testosterone and estradiol deficiency on obesity and glucose metabolism in male Göttingen minipigs Steroids. 75: 676-684. PMID 20420845 DOI: 10.1016/J.Steroids.2010.04.004  0.411
2009 Christoffersen B, Ribel U, Raun K, Golozoubova V, Pacini G. Evaluation of different methods for assessment of insulin sensitivity in Göttingen minipigs: Introduction of a new, simpler method American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 297. PMID 19710388 DOI: 10.1152/Ajpregu.90851.2008  0.305
2007 Raun K, Voss Pv, Knudsen LB. Liraglutide, a once-daily human glucagon-like peptide-1 analog, minimizes food intake in severely obese minipigs. Obesity. 15: 1710-1716. PMID 17636089 DOI: 10.1038/Oby.2007.204  0.41
2007 Raun K, Voss Pv, Gotfredsen CF, Golozoubova V, Rolin B, Knudsen LB. Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not Diabetes. 56: 8-15. PMID 17192459 DOI: 10.2337/Db06-0565  0.461
2006 Christoffersen BØ, Raun K, Svendsen O, Fledelius C, Golozoubova V. Evalution of the castrated male Sprague-Dawley rat as a model of the metabolic syndrome and type 2 diabetes. International Journal of Obesity. 30: 1288-1297. PMID 16505834 DOI: 10.1038/Sj.Ijo.0803261  0.36
2005 Boggiano MM, Chandler PC, Oswald KD, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Schindler M, Arndt K, Rudolf K, Mark M, Schoelch C, Joost HG, ... ... Raun K, et al. PYY3-36 as an anti-obesity drug target. Obesity Reviews : An Official Journal of the International Association For the Study of Obesity. 6: 307-22. PMID 16246216 DOI: 10.1111/J.1467-789X.2005.00218.X  0.39
2005 Malmlöf K, Zaragoza F, Golozoubova V, Refsgaard HH, Cremers T, Raun K, Wulff BS, Johansen PB, Westerink B, Rimvall K. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight. International Journal of Obesity (2005). 29: 1402-12. PMID 16151415 DOI: 10.1038/Sj.Ijo.0803036  0.449
2002 Bail HJ, Raschke MJ, Kolbeck S, Krummrey G, Windhagen HJ, Weiler A, Raun K, Mosekilde L, Haas NP. Recombinant species-specific growth hormone increases hard callus formation in distraction osteogenesis. Bone. 30: 117-24. PMID 11792573 DOI: 10.1016/S8756-3282(01)00628-7  0.317
2001 Hansen TK, Ankersen M, Raun K, Hansen BS. Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin. Bioorganic & Medicinal Chemistry Letters. 11: 1915-1918. PMID 11459660 DOI: 10.1016/S0960-894X(01)00345-6  0.303
2000 Peschke B, Ankersen M, Hansen TK, Hansen BS, Lau J, Nielsen KK, Raun K. New highly potent dipeptidic growth hormone secretagogues with low molecular weight. European Journal of Medicinal Chemistry. 35: 599-618. PMID 10906412 DOI: 10.1016/S0223-5234(00)00160-4  0.351
1999 Hansen BS, Raun K, Nielsen KK, Johansen PB, Hansen TK, Peschke B, Lau J, Andersen PH, Ankersen M. Pharmacological characterisation of a new oral GH secretagogue, NN703. European Journal of Endocrinology / European Federation of Endocrine Societies. 141: 180-9. PMID 10427162 DOI: 10.1530/Eje.0.1410180  0.379
1999 Raschke MJ, Bail H, Windhagen HJ, Kolbeck SF, Weiler A, Raun K, Kappelgard A, Skiaerbaek C, Haas NP. Recombinant Growth Hormone Accelerates Bone Regenerate Consolidation in Distraction Osteogenesis Bone. 24: 81-88. PMID 9951774 DOI: 10.1016/S8756-3282(98)00158-6  0.31
1998 Hansen TK, Ankersen M, Hansen BS, Raun K, Nielsen KK, Lau J, Peschke B, Lundt BF, Thøgersen H, Johansen NL, Madsen K, Andersen PH. Novel orally active growth hormone secretagogues Journal of Medicinal Chemistry. 41: 3705-3714. PMID 9733496 DOI: 10.1021/Jm980197U  0.326
1998 Ankersen M, Johansen NL, Madsen K, Hansen BS, Raun K, Nielsen KK, Thøgersen H, Hansen TK, Peschke B, Lau J, Lundt BF, Andersen PH. A New Series of Highly Potent Growth Hormone-Releasing Peptides Derived from Ipamorelin Journal of Medicinal Chemistry. 41: 3699-3704. PMID 9733495 DOI: 10.1021/Jm9801962  0.306
Show low-probability matches.